APA (7th ed.) Citation

Wunderink, R., Giamarellos-Bourboulis, E., Rahav, G., Mathers, A., Bassetti, M., Solomkin, J., . . . Kaye, K. S. (2017). Meropenem-Vaborbactam vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection. Open forum infectious diseases, 4(suppl_1), S536-S537. https://doi.org/10.1093/ofid/ofx163.1397

Chicago Style (17th ed.) Citation

Wunderink, Richard, et al. "Meropenem-Vaborbactam Vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection." Open Forum Infectious Diseases 4, no. suppl_1 (2017): S536-S537. https://doi.org/10.1093/ofid/ofx163.1397.

MLA (9th ed.) Citation

Wunderink, Richard, et al. "Meropenem-Vaborbactam Vs. Best AvailableTherapy for Carbapenem-ResistantEnterobacteriaceae Infections in TANGO II: PrimaryOutcomes by Site of Infection." Open Forum Infectious Diseases, vol. 4, no. suppl_1, 2017, pp. S536-S537, https://doi.org/10.1093/ofid/ofx163.1397.